ClinicalTrials.Veeva

Menu

Surgery Treatment of Type 2 Diabetes Mellitus Patients With Grade 1 Obesity and Overweight

H

Hospital Federal de Bonsucesso

Status

Unknown

Conditions

Overweight
Diabetes Mellitus
Obesity

Treatments

Procedure: Duodenal Ileal Interposition with Sleeve Gastrectomy

Study type

Interventional

Funder types

Other

Identifiers

NCT03333642
67955917.2.0000.5253

Details and patient eligibility

About

This study evaluate the Duodenal Ileal Interposition with Sleeve Gastrectomy for Type 2 Diabetes Mellitus in grade 1 obesity and overweight patients.

Full description

A clinical trial, 1-arm treatment (Duodenal Ileal Interposition with Sleeve Gastrectomy for Type 2 Diabetes Mellitus), including 50 research subjects with type 2 diabetes mellitus and obesity class I or overweight. The main objective is to analyse the effect on glycemic control after 2 years of follow-up.

Enrollment

50 estimated patients

Sex

All

Ages

20 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Documented diagnosis of type 2 diabetes mellitus;
  • Patients of both sexes treated with oral antidiabetic agents and / or insulins,
  • Stable antidiabetic medication in the last 8 weeks prior to selection, if the therapy includes insulin, the mean daily dose should not have been changed by more than 10% in the last 8 weeks;
  • HbA1c> 7.0%;
  • Age> 20 years and <65 years;
  • Body mass index (BMI) of 25 to 35 kg / m²;
  • Agree to sign the consent form;

Exclusion criteria

  • Diabetes mellitus type 1 (anti-glutamic acid decarboxylase(GAD) positive) or anti-GAD negative body with low β-cell function (peptide C after stimulation <0.5 ng / ml);
  • Recent vascular event (myocardial infarction, coronary angioplasty or encephalic vascular accident in the last 6 months);
  • Malignant neoplasm;
  • Portal hypertension;
  • Difficulty to cooperate with segment;
  • Low ability to understand surgery;
  • Unrealistic expectations of results;
  • Cognitive deficit;
  • Current pregnancy;
  • Moderate or severe mood disorder; severe anxiety; eating disorders (based on Substance-Related Disorders DSM-V criteria);
  • Chemical dependence or alcoholism (based on Substance-Related Disorders DSM-V criteria).

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

50 participants in 1 patient group

Duodenal Ileal interposition
Experimental group
Description:
Duodenal Ileal Interposition with Sleeve Gastrectomy.
Treatment:
Procedure: Duodenal Ileal Interposition with Sleeve Gastrectomy

Trial contacts and locations

1

Loading...

Central trial contact

Leonardo R Ferraz, MD; Thiago B de Abreu, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems